Bioresorbable Vascular Scaffold Market (Product Type: Everolimus-eluting Device, Novolimus-eluting Device, Sirolimus-eluting Device, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

TMR's report on the global Bioresorbable Vascular Scaffold market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Bioresorbable Vascular Scaffold market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Bioresorbable Vascular Scaffold market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Bioresorbable Vascular Scaffold market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Bioresorbable Vascular Scaffold market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Bioresorbable Vascular Scaffold market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Bioresorbable Vascular Scaffold market.

The report delves into the competitive landscape of the global Bioresorbable Vascular Scaffold market. Key players operating in the global Bioresorbable Vascular Scaffold market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Bioresorbable Vascular Scaffold market profiled in this report.

Key Questions Answered in Global Bioresorbable Vascular Scaffold Market Report:

What is the sales/revenue generated by Bioresorbable Vascular Scaffold across all regions during the forecast period?
What are the opportunities in the global Bioresorbable Vascular Scaffold market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Bioresorbable Vascular Scaffold Market - Research Objectives and Research Approach

The comprehensive report on the global Bioresorbable Vascular Scaffold market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Bioresorbable Vascular Scaffold market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Bioresorbable Vascular Scaffold market.

Product Code: TMRGL32003

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bioresorbable Vascular Scaffold Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Development
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, 2017 - 2031

5. Key Insights

5.1. Technological Advancement
5.2. Disease Incidence and Prevalence
5.3. Regulatory Analysis
5.4. COVID-19 Impact Analysis

6. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Product Type

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017 - 2031
- 6.3.1. Everolimus-eluting Device
- 6.3.2. Novolimus-eluting Device
- 6.3.3. Sirolimus-eluting Device
- 6.3.4. Others (Rapamycin, etc.)
6.4. Market Attractiveness Analysis, By Product Type

7. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Disease Type

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease Type, 2017 - 2031
- 7.3.1. Coronary Artery Disease
- 7.3.2. Peripheral Artery Disease
7.4. Market Attractiveness Analysis, By Disease Type

8. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Material Type

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Material Type, 2017 - 2031
- 8.3.1. Poly-L-Lactic Acid (PLLA)
- 8.3.2. Tyrosine-derived Polycarbonate
- 8.3.3. Others (Polydioxanone, etc.)
8.4. Market Attractiveness Analysis, By Material Type

9. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by End-user

9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017 - 2031
- 9.3.1. Hospital
- 9.3.2. Ambulatory Surgical Center
- 9.3.3. Cardiac Catheterization Lab
- 9.3.4. Others (Research Institute, etc.)
9.4. Market Attractiveness Analysis, By End-user

10. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, By Region

11. North America Bioresorbable Vascular Scaffold Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017 - 2031
- 11.2.1. Everolimus-eluting Device
- 11.2.2. Novolimus-eluting Device
- 11.2.3. Sirolimus-eluting Device
- 11.2.4. Others (Rapamycin, etc.)
11.3. Market Value Forecast, by Disease Type, 2017 - 2031
- 11.3.1. Coronary Artery Disease
- 11.3.2. Peripheral Artery Disease
11.4. Market Value Forecast, by Material Type, 2017 - 2031
- 11.4.1. Poly-L-Lactic Acid (PLLA)
- 11.4.2. Tyrosine-derived Polycarbonate
- 11.4.3. Others (Polydioxanone, etc.)
11.5. Market Value Forecast, by End-user, 2017 - 2031
- 11.5.1. Hospital
- 11.5.2. Ambulatory Surgical Center
- 11.5.3. Cardiac Catheterization Lab
- 11.5.4. Others (Research Institute, etc.)
11.6. Market Value Forecast, by Country, 2017 - 2031
- 11.6.1. U.S.
- 11.6.2. Canada
11.7. Market Attractiveness Analysis
- 11.7.1. By Product Type
- 11.7.2. By Disease Type
- 11.7.3. By Material Type
- 11.7.4. By End-user
- 11.7.5. By Country

12. Europe Bioresorbable Vascular Scaffold Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017 - 2031
- 12.2.1. Everolimus-eluting Device
- 12.2.2. Novolimus-eluting Device
- 12.2.3. Sirolimus-eluting Device
- 12.2.4. Others (Rapamycin, etc.)
12.3. Market Value Forecast, by Disease Type, 2017 - 2031
- 12.3.1. Coronary Artery Disease
- 12.3.2. Peripheral Artery Disease
12.4. Market Value Forecast, by Material Type, 2017 - 2031
- 12.4.1. Poly-L-Lactic Acid (PLLA)
- 12.4.2. Tyrosine-derived Polycarbonate
- 12.4.3. Others (Polydioxanone, etc.)
12.5. Market Value Forecast, by End-user, 2017 - 2031
- 12.5.1. Hospital
- 12.5.2. Ambulatory Surgical Center
- 12.5.3. Cardiac Catheterization Lab
- 12.5.4. Others (Research Institute, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
- 12.7.1. By Product Type
- 12.7.2. By Disease Type
- 12.7.3. By Material Type
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region

13. Asia Pacific Bioresorbable Vascular Scaffold Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017 - 2031
- 13.2.1. Everolimus-eluting Device
- 13.2.2. Novolimus-eluting Device
- 13.2.3. Sirolimus-eluting Device
- 13.2.4. Others (Rapamycin, etc.)
13.3. Market Value Forecast, by Disease Type, 2017 - 2031
- 13.3.1. Coronary Artery Disease
- 13.3.2. Peripheral Artery Disease
13.4. Market Value Forecast, by Material Type, 2017 - 2031
- 13.4.1. Poly-L-Lactic Acid (PLLA)
- 13.4.2. Tyrosine-derived Polycarbonate
- 13.4.3. Others (Polydioxanone, etc.)
13.5. Market Value Forecast, by End-user, 2017 - 2031
- 13.5.1. Hospital
- 13.5.2. Ambulatory Surgical Center
- 13.5.3. Cardiac Catheterization Lab
- 13.5.4. Others (Research Institute, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
- 13.7.1. By Product Type
- 13.7.2. By Disease Type
- 13.7.3. By Material Type
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region

14. Latin America Bioresorbable Vascular Scaffold Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017 - 2031
- 14.2.1. Everolimus-eluting Device
- 14.2.2. Novolimus-eluting Device
- 14.2.3. Sirolimus-eluting Device
- 14.2.4. Others (Rapamycin, etc.)
14.3. Market Value Forecast, by Disease Type, 2017 - 2031
- 14.3.1. Coronary Artery Disease
- 14.3.2. Peripheral Artery Disease
14.4. Market Value Forecast, by Material Type, 2017 - 2031
- 14.4.1. Poly-L-Lactic Acid (PLLA)
- 14.4.2. Tyrosine-derived Polycarbonate
- 14.4.3. Others (Polydioxanone, etc.)
14.5. Market Value Forecast, by End-user, 2017 - 2031
- 14.5.1. Hospital
- 14.5.2. Ambulatory Surgical Center
- 14.5.3. Cardiac Catheterization Lab
- 14.5.4. Others (Research Institute, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
- 14.7.1. By Product Type
- 14.7.2. By Disease Type
- 14.7.3. By Material Type
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region

15. Middle East & Africa Bioresorbable Vascular Scaffold Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017 - 2031
- 15.2.1. Everolimus-eluting Device
- 15.2.2. Novolimus-eluting Device
- 15.2.3. Sirolimus-eluting Device
- 15.2.4. Others (Rapamycin, etc.)
15.3. Market Value Forecast, by Disease Type, 2017 - 2031
- 15.3.1. Coronary Artery Disease
- 15.3.2. Peripheral Artery Disease
15.4. Market Value Forecast, by Material Type, 2017 - 2031
- 15.4.1. Poly-L-Lactic Acid (PLLA)
- 15.4.2. Tyrosine-derived Polycarbonate
- 15.4.3. Others (Polydioxanone, etc.)
15.5. Market Value Forecast, by End-user, 2017 - 2031
- 15.5.1. Hospital
- 15.5.2. Ambulatory Surgical Center
- 15.5.3. Cardiac Catheterization Lab
- 15.5.4. Others (Research Institute, etc.)
15.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
- 15.7.1. By Product Type
- 15.7.2. By Disease Type
- 15.7.3. By Material Type
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2021)
16.3. Company Profiles
- 16.3.1. Kyoto Medical Planning Co., Ltd.
  - 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.1.2. Test Type Portfolio
  - 16.3.1.3. Financial Overview
  - 16.3.1.4. SWOT Analysis
  - 16.3.1.5. Strategic Overview
- 16.3.2. BIOTRONIK Group of Companies
  - 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.2.2. Test Type Portfolio
  - 16.3.2.3. Financial Overview
  - 16.3.2.4. SWOT Analysis
  - 16.3.2.5. Strategic Overview
- 16.3.3. REVA Medical
  - 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.3.2. Test Type Portfolio
  - 16.3.3.3. Financial Overview
  - 16.3.3.4. SWOT Analysis
  - 16.3.3.5. Strategic Overview
- 16.3.4. Elixir Medical
  - 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.4.2. Test Type Portfolio
  - 16.3.4.3. Financial Overview
  - 16.3.4.4. SWOT Analysis
  - 16.3.4.5. Strategic Overview
- 16.3.5. Arterius
  - 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.5.2. Test Type Portfolio
  - 16.3.5.3. Financial Overview
  - 16.3.5.4. SWOT Analysis
  - 16.3.5.5. Strategic Overview
- 16.3.6. Meril Life Sciences Pvt. Ltd
  - 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.6.2. Test Type Portfolio
  - 16.3.6.3. Financial Overview
  - 16.3.6.4. SWOT Analysis
  - 16.3.6.5. Strategic Overview
- 16.3.7. S3V Vascular Technologies
  - 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.7.2. Test Type Portfolio
  - 16.3.7.3. Financial Overview
  - 16.3.7.4. SWOT Analysis
  - 16.3.7.5. Strategic Overview
- 16.3.8. Zorion medical
  - 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.8.2. Test Type Portfolio
  - 16.3.8.3. Financial Overview
  - 16.3.8.4. SWOT Analysis
  - 16.3.8.5. Strategic Overview
- 16.3.9. Medtronic (development phase)
  - 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.9.2. Test Type Portfolio
  - 16.3.9.3. Financial Overview
  - 16.3.9.4. SWOT Analysis
  - 16.3.9.5. Strategic Overview

Product Code: TMRGL32003

List of Tables

Table 01: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 03: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 04: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 08: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 09: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 10: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 13: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 14: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 15: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 18: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 19: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 20: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 23: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 24: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 25: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 28: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 29: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 30: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 03: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 04: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 05: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 06: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
Figure 07: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
Figure 08: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
Figure 09: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
Figure 10: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Region, 2022 and 2031
Figure 11: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Region, 2023-2031
Figure 12: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
Figure 13: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country, 2022 and 2031
Figure 14: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country, 2023-2031
Figure 15: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 16: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 17: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 18: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 19: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
Figure 20: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
Figure 21: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
Figure 22: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
Figure 23: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
Figure 24: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 25: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 26: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 27: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 28: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 29: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 30: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
Figure 31: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
Figure 32: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
Figure 33: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
Figure 34: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
Figure 35: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 37: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 38: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 39: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 40: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 41: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
Figure 42: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
Figure 43: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
Figure 44: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
Figure 45: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
Figure 46: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 47: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 48: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 49: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 50: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 51: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 52: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
Figure 53: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
Figure 54: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
Figure 55: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
Figure 56: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
Figure 57: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 59: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 60: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 61: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 62: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 63: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
Figure 64: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
Figure 65: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
Figure 66: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
Figure 67: Global Bioresorbable Vascular Scaffold Market Share Analysis, by Company, 2022

Bioresorbable Vascular Scaffold Market (Product Type: Everolimus-eluting Device, Novolimus-eluting Device, Sirolimus-eluting Device, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Description

Table of Contents

List of Tables

Bioresorbable Vascular Scaffold Market - Scope of Report

Key Questions Answered in Global Bioresorbable Vascular Scaffold Market Report:

Bioresorbable Vascular Scaffold Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Bioresorbable Vascular Scaffold Market

4. Market Overview

5. Key Insights

6. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Product Type

7. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Disease Type

8. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Material Type

9. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by End-user

10. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Region

11. North America Bioresorbable Vascular Scaffold Market Analysis and Forecast

12. Europe Bioresorbable Vascular Scaffold Market Analysis and Forecast

13. Asia Pacific Bioresorbable Vascular Scaffold Market Analysis and Forecast

14. Latin America Bioresorbable Vascular Scaffold Market Analysis and Forecast

15. Middle East & Africa Bioresorbable Vascular Scaffold Market Analysis and Forecast

16. Competition Landscape

List of Tables

List of Figures